Meeting report Considerations for trial design and endpoints in licensing therapeutic HPV1618 vaccines to prevent cervical cancer

Peter M DullSharon L AchillesRafi AhmedRuanne V BarnabasE et alPaul Ruff2024-11-192024-11-19WOS0264-410Xhttps://hdl.handle.net/10539/42728Meeting report Considerations for trial design and endpoints in licensing therapeutic HPV1618 vaccines to prevent cervical cancerJournal Article